Website is not updated since a while!

Total dividend bookyear 2019: € 1.240*

Final dividend

proposed amount
€ 1.240
announcement date
Apr 30, 2020
ex-coupon date
May 4, 2020
payment date
May 6, 2020

Source: UCB website

A dividend in respect of the year ended 31 December 2019 of €1.24 per share will be submitted to approval at the annual general meeting of the shareholders on 30 April 2020. 

Total dividend bookyear 2018: € 1.210*

Final dividend

proposed amount
€ 1.210
announcement date
Apr 25, 2019
ex-coupon date
payment date
Apr 30, 2019

In-line with UCB’s long-term dividend policy, the Board proposes a gross dividend of € 1.21 per share (2017: € 1.18). If the dividend is approved by the Annual General Meeting on 25 April 2019, the net dividend of € 0.847 per share will be payable as of 30 April 2019 against the delivery of coupon #22.

Total dividend bookyear 2017: € 1.180*

Final dividend

proposed amount
€ 1.180
announcement date
Apr 26, 2018
ex-coupon date
Apr 27, 2018
payment date
May 2, 2018
Unfortunately we don't have this information in English yet. Currently the Dutch version is displayed.

De Raad van Bestuur van UCB stelt een dividend voor van € 1,18 per aandeel (bruto), een stijging van drie eurocent of 2,6%.

Coupon # 21
Ex-dividend: 27 April 2018
Record date: 30 April 2018
Payment: 2 May 2018

Total dividend bookyear 2016: € 1.150*

Final dividend

proposed amount
€ 1.150
announcement date
Apr 27, 2017
ex-coupon date
Apr 28, 2017
payment date
May 3, 2017

The Board of Directors proposes to pay a gross dividend of € 1.15 per share. If this dividend proposal is approved by the General Meeting on 27 April 2017, the net dividend of € 0.805 per share will be payable as of 3 May 2017 against the delivery of coupon #20. The shares held by UCB SA are not entitled to a dividend.

Per 4 January 2017, 191 426 122 UCB shares are entitled to a dividend, representing a total distribution of € 220 million. This amount may fluctuate depending the number of UCB shares held by UCB SA on the dividend approval date. The Board of Directors will communicate at the general meeting the total number of UCB shares entitled to a dividend and will submit the aggregate amount to be distributed for approval. The annual accounts of 2016 will be adapted accordingly.

Total dividend bookyear 2015: € 1.100*

Final dividend

proposed amount
€ 1.100
announcement date
Apr 28, 2016
ex-coupon date
Apr 29, 2016
payment date
May 3, 2016

The gross dividends paid in 2015 and 2014 were €205 million (€1.06 per share) and €202 million (€1.04 per share) respectively.

A dividend in respect of the year ended 31 December 2015 of €1.10 per share, amounting to a total dividend of €210 million, is to be proposed at the annual general meeting of the shareholders on 28 April 2016.

In accordance with IAS 10, events after the reporting period, the proposed dividend has not been recognized as a liability at year-end.

Coupon nr. 19

Dividend history

financial events

Company information

Source: company website, April 2018

UCB is a global biopharmaceutical company, with a focus on neurology and immunology.

Our business is strong. Total revenue grew to €4.5 billion in 2017. We are more than 7,500 people in all four corners of the globe, inspired by patients and driven by science.

Looking ahead, we have a solid platform for continuous growth with our core products Cimzia®, Vimpat®, Neupro®, Keppra® and Briviact®, and we are preparing the launch of a potential medicine to help patients with osteoporosis. At the same time, we are very excited about the progress in our early research pipeline.

Dividend policy

Source: company website, April 2018

The Board of Directors intends to continue to sustain a dynamic dividend policy, consistent with the long term growth prospects of the Company, offering gradual increase in dividend, and as far as possible not to reduce it, irrespective of the short term income variations.